BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 24367693)

  • 1. Correlations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the R6/1 mouse model of Huntington's disease.
    Rattray I; Smith EJ; Crum WR; Walker TA; Gale R; Bates GP; Modo M
    PLoS One; 2013; 8(12):e84726. PubMed ID: 24367693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the R6/2 mouse model of HD.
    Rattray I; Smith E; Gale R; Matsumoto K; Bates GP; Modo M
    PLoS One; 2013; 8(4):e60012. PubMed ID: 23593159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.
    Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB
    J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar Progression of Morphological and Metabolic Phenotype in R6/2 Mice with Different CAG Repeats Revealed by In Vivo Magnetic Resonance Imaging and Spectroscopy.
    Sawiak SJ; Wood NI; Morton AJ
    J Huntingtons Dis; 2016 Oct; 5(3):271-283. PubMed ID: 27662335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease.
    Dufour BD; McBride JL
    Neurobiol Dis; 2019 Jan; 121():214-229. PubMed ID: 30292559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic expression of huntingtin causes distinct metabolic changes in Huntington's disease mice.
    Dickson E; Soylu-Kucharz R; Petersén Å; Björkqvist M
    Mol Metab; 2022 Mar; 57():101439. PubMed ID: 35007790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations of Behavioral Deficits with Brain Pathology Assessed through Longitudinal MRI and Histopathology in the HdhQ150/Q150 Mouse Model of Huntington's Disease.
    Rattray I; Smith EJ; Crum WR; Walker TA; Gale R; Bates GP; Modo M
    PLoS One; 2017; 12(1):e0168556. PubMed ID: 28099507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal analysis of the behavioural phenotype in R6/1 (C57BL/6J) Huntington's disease transgenic mice.
    Brooks SP; Janghra N; Workman VL; Bayram-Weston Z; Jones L; Dunnett SB
    Brain Res Bull; 2012 Jun; 88(2-3):94-103. PubMed ID: 21272613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An independent study of the preclinical efficacy of C2-8 in the R6/2 transgenic mouse model of Huntington's disease.
    Wang N; Lu XH; Sandoval SV; Yang XW
    J Huntingtons Dis; 2013; 2(4):443-51. PubMed ID: 25062731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic deletion of transglutaminase 2 does not rescue the phenotypic deficits observed in R6/2 and zQ175 mouse models of Huntington's disease.
    Menalled LB; Kudwa AE; Oakeshott S; Farrar A; Paterson N; Filippov I; Miller S; Kwan M; Olsen M; Beltran J; Torello J; Fitzpatrick J; Mushlin R; Cox K; McConnell K; Mazzella M; He D; Osborne GF; Al-Nackkash R; Bates GP; Tuunanen P; Lehtimaki K; Brunner D; Ghavami A; Ramboz S; Park L; Macdonald D; Munoz-Sanjuan I; Howland D
    PLoS One; 2014; 9(6):e99520. PubMed ID: 24955833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Huntington's disease mouse models: unraveling the pathology caused by CAG repeat expansion.
    Kaye J; Reisine T; Finkbeiner S
    Fac Rev; 2021; 10():77. PubMed ID: 34746930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentiviral delivery of human erythropoietin attenuates hippocampal atrophy and improves cognition in the R6/2 mouse model of Huntington's disease.
    Rolfes S; Munro DAD; Lyras EM; Matute E; Ouk K; Harms C; Böttcher C; Priller J
    Neurobiol Dis; 2020 Oct; 144():105024. PubMed ID: 32702387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquilin-1 overexpression increases the lifespan and delays accumulation of Huntingtin aggregates in the R6/2 mouse model of Huntington's disease.
    Safren N; El Ayadi A; Chang L; Terrillion CE; Gould TD; Boehning DF; Monteiro MJ
    PLoS One; 2014; 9(1):e87513. PubMed ID: 24475300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice.
    Stack EC; Kubilus JK; Smith K; Cormier K; Del Signore SJ; Guelin E; Ryu H; Hersch SM; Ferrante RJ
    J Comp Neurol; 2005 Oct; 490(4):354-70. PubMed ID: 16127709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington's disease.
    Moffitt H; McPhail GD; Woodman B; Hobbs C; Bates GP
    PLoS One; 2009 Nov; 4(11):e8025. PubMed ID: 19956633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of magnetic resonance imaging for anatomical phenotyping of the R6/2 mouse model of Huntington's disease.
    Sawiak SJ; Wood NI; Williams GB; Morton AJ; Carpenter TA
    Neurobiol Dis; 2009 Jan; 33(1):12-9. PubMed ID: 18930823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise attenuates neuropathology and has greater benefit on cognitive than motor deficits in the R6/1 Huntington's disease mouse model.
    Harrison DJ; Busse M; Openshaw R; Rosser AE; Dunnett SB; Brooks SP
    Exp Neurol; 2013 Oct; 248():457-69. PubMed ID: 23911978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease.
    Cummings DM; Alaghband Y; Hickey MA; Joshi PR; Hong SC; Zhu C; Ando TK; André VM; Cepeda C; Watson JB; Levine MS
    J Neurophysiol; 2012 Jan; 107(2):677-91. PubMed ID: 22072510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation of umbilical cord-derived mesenchymal stem cells into the striata of R6/2 mice: behavioral and neuropathological analysis.
    Fink KD; Rossignol J; Crane AT; Davis KK; Bombard MC; Bavar AM; Clerc S; Lowrance SA; Song C; Lescaudron L; Dunbar GL
    Stem Cell Res Ther; 2013 Oct; 4(5):130. PubMed ID: 24456799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Behavioral, Neuropathological, Brain Metabolic and Key Molecular Changes in zQ175 Knock-In Mouse Model of Huntington's Disease.
    Peng Q; Wu B; Jiang M; Jin J; Hou Z; Zheng J; Zhang J; Duan W
    PLoS One; 2016; 11(2):e0148839. PubMed ID: 26859386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.